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Studies towards the total synthesis of novel marine diterpene
havellockate. Construction of the tetracyclic core
Goverdhan Mehta* and R. Senthil Kumaran
Department of Organic Chemistry, Indian Institute of Science, Bangalore 560 012, India
Abstract—The synthesis of the tetracyclic core present in the novel marine diterpenoid havellockate 1 has been accomplished from
the readily available endo-dicyclopentadienone-10-ethylene ketal 3 as a prelude to the projected total synthesis of the natural
product.
Diterpenes in general and particularly those of marine
origin are rich in skeletal diversity and structural com-
plexity and many of them possess impressive and wide
ranging biological activities.1 These attributes make
diterpenenoids from marine sources attractive and chal-
lenging targets of synthesis.1 In 1998, a new diterpenoid
named havellockate 1, bearing a novel skeleton, was
isolated from the soft coral species Sinularia granosa
collected from the Havellock island of the Andaman
and Nicobar group of Islands in the Indian ocean.2 The
structure of havellockate 1 was determined on the basis
of spectral data and confirmed by single-crystal X-ray
analysis.2 The skeleton of 1 is biogenetically quite
intriguing and is probably derived from a cembranoid
precursor through extensive restructuring and concomi-
tant oxy-functionalization. The tetracyclic core present
in the complex structure of 1 with eight stereogenic
centers and many functionalities consists of a cis-fused
hydrindane moiety to which two -lactone units are
appended, one of them being spiro-fused. These struc-
tural features of 1 aroused our interest in its total
synthesis. As the first objective, we targeted the tetra-
cyclic core structure 2, identified through retrosynthetic
considerations indicated in Scheme 1. It was surmized
that with the acquisition of the tetracyclic ketolactone
2, the overall strategy could be tactically modified and
adopted for the synthesis of 1. Herein, we report a
synthesis of tetracyclic ketolactone 2 with complete
regio- and stereocontrol.
For the synthesis of 2, readily available3 endo-dicy-
clopentadienone 3 was chosen as the starting material
as the cis-hydrindane moiety is embedded into this
framework (see bold portion in 3) and can be unrav-
elled by removing the ketal bearing C-10 carbon
bridge.4 Stereoselective epoxidation of the enone moiety
in 3 to exo-epoxide 4 and hydride reduction furnished
the trans 1,3-diol 5 (Scheme 2).5 The endo hydroxyl
group in 5 was protected through intramolecular halo-
etherification to furnish tetracyclic bromoether 6.5 The
exo-hydroxyl group in 6 was now inverted through
oxidation to ketone 7 and stereoselective reduction
Scheme 1.
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Scheme 2. Reagents and conditions : (a) 30% H2O2, 6N NaOH, MeOH, 0°C, 30 min, 80%; (b) LAH, THF, 0°C to reflux, 4.5 h,
88%; (c) NBS, DCM, rt, 3 h, 90%; (d) PCC, DCM, 4 A molecular sieves, 0°C to rt, 1 h, 85%; (e) NaBH4, MeOH, 0°C, 15 min,
80%; (f) Zn/NH4Cl, THF/H2O (9:1), 50°C, 2 h, 65%; (g) BnBr, NaH,
nBu4NI (cat.), 0°C to rt, 10 h, 72%; (h) Amberlyst-15,
CH3COCH3, 65°C, 15 h, 80%; (i) 90% aq. HOAc, 30% H2O2, CH3COONa, 0°C to rt, 6 h, 45%; (j) LAH, THF, 0°C, 2 h, 90%;
(k) TBDMSCl, imidazole, DMAP (cat.), DCM, rt, 3 h, 70%; (l) PCC, DCM, 4 A molecular sieves, 0°C to rt, 45 min, 89%.
from the exo-face to deliver the endo-alcohol 8 (Scheme
2).5 On exposure to zinc metal, the olefinic and the
hydroxyl groups could be released back from the bro-
moether 8 to furnish the symmetrical endo,endo-1,3-diol
9.5 Besides having the requisite stereochemistry of the
hydroxyl groups, the symmetrical nature of 9 circum-
vented any regiochemical problems that could surface
during the opening of the C-10 bridge (vide infra). The
two endo-hydroxyl groups in 9 were protected as the
benzyl ethers, then ketal deprotection led to the norbor-
nenone derivative 10 (Scheme 2). Carefully controlled
Baeyer–Villiger oxidation on 10 delivered a single lac-
tone 11, which was reductively cleaved to unravel the
cis-hydrindane 12 with secured stereochemistry at six
stereogenic centers. The primary hydroxyl group in 12
was selectively protected as the TBDMS-ether 13 and
the secondary alcohol oxidized with PCC to deliver
enone 14, a key substrate on which two lactone moi-
eties present in the target compound 2 were to be
installed (Scheme 2).
For the stereoselective spiro-lactone annulation at the
carbonyl site in 14, a RCM based protocol was pre-
ferred.6 Addition of vinylmagnesium bromide to 14
occurred exclusively from the convex face to give vinyl
alcohol 15 (Scheme 3). Allylation of the tertiary
hydroxy group in 15 was smooth and the allyl-ether 16
was readily realized. Exposure of 16 to Grubbs’ catalyst
gave spiro-annulated dihydrofuran 17 in excellent yield
(Scheme 3). The spiro-fused dihydrofuran moiety in 17
could be further oxidized to the corresponding -lac-
tone.7 The TBDMS protective group in 17 was now
dispensed with and the resulting primary hydroxyl
group was oxidized in a controlled manner to give the
exo-aldehyde 18. The next task was to invert the alde-
hyde stereochemistry in 18 and for this purpose the
cyclohexene double bond in it was isomerized in the
presence of DBU to deliver the ,-unsaturated alde-
hyde 19. Catalytic hydrogenation of 19, besides liberat-
ing the benzyl protected hydroxyl groups, also reduced
the ,-unsaturated aldehyde functionality from the
preferred exo-face to deliver the endo-aldehyde group,
which was concomitantly captured by the appropriately
positioned endo-hydroxyl group resulting in the lactol
20. PCC oxidation of 20 led to the target compound 2,
in the process generating not only the second -lactone
ring but also the cyclopentanone moiety required to
set-up the tertiary alcohol unit present in the natural
product 1.
In short, we have accomplished a synthesis of the
tetracyclic core 2 present in the marine diterpenoid
havellockate 1, with good regio- and stereochemical
control, from a readily available dicyclopentadienone
derivative 3. The overall synthetic strategy delineated
here for havellockate 1 is also amenable to adaptation
for the synthesis of many novel but related diterpenoid
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Scheme 3. Reagents and conditions : (a) vinylmagnesium bromide, THF, 0°C to rt, 10 h, 70%; (b) allyl bromide, NaH, nBu4NI
(cat.), THF, 0°C, 1 day, 78%; (c) Grubbs’ catalyst (20 mol%), DCM, rt, 2 h 90%; (d) nBu4NF, THF, 0°C to rt, 10 h, 65%; (e)
PCC, DCM, 4 A molecular sieves, 10 min, 0°C, 70%; (f) DBU, DCM, 0°C to rt, 1.5 h, 60%; (g) H2, 10% Pd–C, EtOAc, rt, 2 h,
50%; (h) PCC, DCM, 4 A molecular sieves, 0°C to rt, 15 h, 70%.
skeleta of marine origin like mandapamate and
isomandapamate.8
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